Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Adamas Pharmaceuticals, Inc.

Adamas Announces New Employment Inducement Grants
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) Congress
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces New Employment Inducement Grants
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Present at Upcoming September Investor Conferences
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces New Employment Inducement Grant
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Reports Second Quarter 2021 Financial Results
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces New Employment Inducement Grant
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Present at Upcoming William Blair Biotech Focus Conference
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Present at Upcoming SVB Leerink CNS Forum
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces New Employment Inducement Grant
From Adamas Pharmaceuticals, Inc.
Via Business Wire
New Data Analysis Supports GOCOVRI as an Important Treatment for Motor Complications for People With Parkinson’s Disease
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Present at Upcoming June Conferences
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Reports First Quarter 2021 Financial Results
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces New Employment Inducement Grant
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Present at Upcoming BofA Conference
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Launches “Picture More Time” Campaign to Raise Awareness and Understanding of the Impact of OFF Time and Dyskinesia for People With Parkinson’s Disease and Care Partners
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Announce First Quarter Financial Results and Host Conference Call on May 10, 2021
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Survey data detailing impact of OFF time and dyskinesia in people affected by Parkinson’s disease presented at American Academy of Neurology (AAN) Annual Meeting
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas Announces Two Presentations for the American Academy of Neurology 73rd Annual Meeting
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Adamas to Present at Upcoming Needham Conference
From Adamas Pharmaceuticals, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.